Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis / Améliorer Les capacités Cognitives Par tDCS Chez Les Patients Souffrants de sclérose en Plaques

NCT02266121 is registered in ClinicalTrials.gov with University Hospital of Mont-Godinne as lead sponsor.

NCT NCT02266121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis / Améliorer Les capacités Cognitives Par tDCS Chez Les Patients Souffrants de sclérose en Plaques
Lead sponsor
University Hospital of Mont-Godinne
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2014
Completion date
May 8, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficits, motor deficits, relapsing remitting multiple sclerosis, secondary-progressive multiple sclerosis